You state some good arguments for Regeneron and I like that pick. I also think they have been in discussions with ViiV and Gilead (both pretty obvious), but ultimately wouldn’t / couldn’t match the royalty due to cannibalization of current products. I don’t think Syneos is the license partner and simply the connection noted in the recent slides due as they are the fallback plan.